Highlights
NASDAQ: IMGN       Immunogen Inc
Last Price Today's Change   Day's Range   Trading Volume
4.88   +0.13 (2.74%)  4.43 - 4.96  2,049,000

Overview

 
Avg Volume (4 weeks):2,159,910
4 Weeks Range:4.19 - 4.96
4 Weeks Price Volatility (%):
89.61%
52 Weeks Range:1.95 - 7.07
52 Weeks Price Volatility (%):
57.23%
Average Price Target: 15.00
Price Target Upside/Downside: +10.12

Headlines



No recent Headlines for this stock.


Business Background

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent. The technology is used in Kadcyla (ado-trastuzumab emtansine)--a registered trademark of Genentech, a member of the Roche Group--to kill solid tumors. Companies such as Amgen, Genentech/Roche, Lilly, Novartis, Sanofi, and Takeda have licensed limited rights to use the ADC technology in their therapies.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers